|
LDLRAD3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.92119661793322E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.8920599999972E-05 |
| Normal-vs-Stage2 |
4.194600E-04 |
| Normal-vs-Stage3 |
1.004720E-03 |
| Normal-vs-Stage4 |
8.042500E-03 |
| Stage1-vs-Stage2 |
3.446600E-01 |
| Stage1-vs-Stage3 |
2.154400E-02 |
| Stage1-vs-Stage4 |
5.934400E-01 |
| Stage2-vs-Stage3 |
6.232300E-02 |
| Stage2-vs-Stage4 |
9.540800E-01 |
| Stage3-vs-Stage4 |
7.900000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.82100004151454E-09 |
| Normal-vs-AfricanAmerican |
1.614920E-04 |
| Normal-vs-Asian |
1.377160E-01 |
| Caucasian-vs-AfricanAmerican |
3.399800E-01 |
| Caucasian-vs-Asian |
4.718800E-01 |
| AfricanAmerican-vs-Asian |
8.101400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.7322000001041E-07 |
| Normal-vs-Female |
1.62620000021541E-07 |
| Male-vs-Female |
1.216460E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.557780E-03 |
| Normal-vs-Extreme_Weight |
2.935300E-03 |
| Normal-vs-Obese |
1.64270999999383E-05 |
| Normal-vs-Extreme_Obese |
1.276200E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.099640E-01 |
| Normal_Weight-vs-Obese |
8.644800E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.850100E-02 |
| Extreme_Weight-vs-Obese |
2.597600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.390400E-01 |
| Obese-vs-Extreme_Obese |
1.471500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.021410E-03 |
| Normal-vs-Age(41-60Yrs) |
1.68320000049071E-07 |
| Normal-vs-Age(61-80Yrs) |
1.73757999999413E-05 |
| Normal-vs-Age(81-100Yrs) |
8.007300E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.011800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.880800E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.181000E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.797900E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.905600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.296000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.70494999999216E-05 |
| Normal-VS-Type2 PRCC |
8.38870000000602E-05 |
| Normal-VS-KIRP CIMP |
1.588310E-04 |
| Normal-VS-Unclassified PRCC |
1.169280E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.163900E-02 |
| Type1 PRCC-VS-KIRP CIMP |
5.038100E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
1.128390E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.957590E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
9.696800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.000200E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.604550E-03 |
| Normal-vs-N1 |
7.350800E-04 |
| Normal-vs-N2 |
9.444200E-02 |
| N0-vs-N1 |
1.405620E-01 |
| N0-vs-N2 |
8.297800E-01 |
| N1-vs-N2 |
6.298400E-01 |
|
|
